Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Boston Convention and Exhibition Center

Jun 23, 2013 8:30 AM - Jun 27, 2013 12:45 PM

415 Summer Street, , Boston, MA 02210 , USA

DIA 2013 49th Annual Meeting: Advancing Therapeutic Innovation and Regulatory Science

EU Update: PROTECT and EnCePP

Session Chair(s)

Stella  Blackburn, MD, MA, MSc, FFPM, FISPE, FRCP

Stella Blackburn, MD, MA, MSc, FFPM, FISPE, FRCP

Strategy

Consultant, United Kingdom

Triage Strategies for Screening Longitudinal Observational Databases

Learning Objective : Discuss the multi-disciplinary approach adopted by the EMA to improve the BR assessment of medicines;Identify the core principles of scientific excellence, independence and transparency introduced by EU regulators and academic community for the conduct of postauthorization studies on safety and BR;Describe the main methods for BR integration and visualization and how they perform in real life case studies.

Speaker(s)

Diana  Hughes, MD

Benefit-risk Integration and Representation: Results From PROTECT

Diana Hughes, MD

Pfizer Inc, United States

Vice President, Worldwide Safety

Niklas  Noren, PhD, MSc

Triage Strategies for Screening Longitudinal Observational Databases

Niklas Noren, PhD, MSc

Uppsala Monitoring Centre (UMC) , Sweden

Chief Science Officer

Stella  Blackburn, MD, MA, MSc, FFPM, FISPE, FRCP

ENCePP: Strengthening Methodology, Transparency and Independence

Stella Blackburn, MD, MA, MSc, FFPM, FISPE, FRCP

Consultant, United Kingdom

Strategy

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.